Healthcare provider profile · identity verified

Heather Butler, MD

Family Practice · OAK CREEK, WI · NPI 1194143966

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	410	124
Lisinopril	Lisinopril	189	56
Levothyroxine Sodium	Levothyroxine Sodium	170	51
Omeprazole	Omeprazole	140	44
Losartan Potassium	Losartan Potassium	135	42
Amlodipine Besylate	Amlodipine Besylate	120	39
Hydrochlorothiazide	Hydrochlorothiazide	104	34
Metoprolol Succinate	Metoprolol Succinate	99	31
Trazodone Hcl	Trazodone Hcl	91	25
Rosuvastatin Calcium	Rosuvastatin Calcium	70	23
Sertraline Hcl	Sertraline Hcl	69	21
Simvastatin	Simvastatin	66	21
Gabapentin	Gabapentin	65	23
Metformin Hcl Er	Metformin Hcl	65	25
Albuterol Sulfate Hfa	Albuterol Sulfate	63	26
Alendronate Sodium	Alendronate Sodium	62	16
Metformin Hcl	Metformin Hcl	60	20
Pantoprazole Sodium	Pantoprazole Sodium	60	23
Furosemide	Furosemide	56	20
Metoprolol Tartrate	Metoprolol Tartrate	52	14
Tizanidine Hcl	Tizanidine Hcl	52	11
Jardiance	Empagliflozin	50	18
Ozempic	Semaglutide	50	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	12
Tamsulosin Hcl	Tamsulosin Hcl	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	21
Duloxetine Hcl	Duloxetine Hcl	42	11
Bupropion Xl	Bupropion Hcl	40	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	11
Eliquis	Apixaban	34	12
Tramadol Hcl	Tramadol Hcl	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Mounjaro	Tirzepatide	33	suppressed
Potassium Chloride	Potassium Chloride	33	suppressed
Prednisone	Prednisone	29	20
Verapamil Er	Verapamil Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Cephalexin	Cephalexin	23	11
Donepezil Hcl	Donepezil Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Lorazepam	Lorazepam	22	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Meloxicam	Meloxicam	21	11
Atenolol	Atenolol	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	16
Celecoxib	Celecoxib	18	suppressed
Famotidine	Famotidine	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Mupirocin	Mupirocin	15	12
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Nystatin	Nystatin	14	13
Topiramate	Topiramate	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error